Access cutting-edge bipolar disorder treatment through this clinical trial at a research site in Imperial. Study-provided care at no cost to qualified participants.
Access bipolar disorder specialists in Imperial at no cost
This study follows strict safety protocols and ethical guidelines
All study-related bipolar disorder treatment provided free
Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population in the United States. This study will assess how safe and effective ABBV-932 is in treating participants with bipolar I or II disorder. ABBV-932 is an investigational drug being developed for the treatment of depressive episodes in adult participants with bipolar I or II disorder. Study doctors put participants in 1 of 4 groups, called treatment arms. There is a 1 in 4 chance that a participant will
Sponsor: AbbVie
Check if you qualify for this bipolar disorder clinical trial in Imperial, CA
If you're searching for bipolar disorder treatment options in Imperial, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Imperial research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bipolar disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.